Hemodialysis and Peritoneal Dialysis Market Overview:
Dialysis is a technique used to remove waste products such as urea and creatinine from blood, which occurs from inappropriate functioning of kidneys and is usually required for people suffering from chronic renal failure. This procedure is performed for treating kidney disorders and is classified into 2 types: hemodialysis and peritoneal dialysis. In hemodialysis, blood is pumped out of blood vessels and is purified with the help of dialyzer and then returned back to the body through vascular access. In peritoneal dialysis, the principle of the procedure remains same, however the inner lining of stomach called peritoneum is used as a filter to purify blood.
The global hemodialysis and peritoneal dialysis market size was valued at $15,681.81 million in 2019, and is projected to reach $22,164.86 million by 2027, registering a CAGR of 6.0%. This market growth is attributed to surge in incidences of kidney related diseases and problems associated with kidney transplants, as kidney transplantation involves a major surgery, a donor match, and a lifetime regime of immunosuppressant medications to prevent body refutation against the organ. In addition, rise in prevalence of lifestyle and chronic diseases such as obesity, diabetes, and hypertension are projected to further supplement the global hemodialysis and peritoneal dialysis market growth. However, rise in complications related to dialysis treatment such as infections, hypotension, fluid overload, and access point bleeding are likely to obstruct growth of the market in the coming years. Similarly, reimbursement policy concerns in emerging nations impedes growth of the market. This is attributed to the fact that reimbursement for dialysis varies widely in terms of amount & duration between different countries and does not necessarily cover real treatment costs, further discouraging patients and physicians to consider the policy usage. On the other hand, shift in preference of patients toward home hemodialysis (HHD), owing to its effective and patient-centered approach and surge in market strategies such as acquisitions, partnerships, product development, and innovation by key players are expected to offer profitable opportunities for growth of the market during the forecast period.
The global hemodialysis and peritoneal dialysis market is segmented on the basis of type, dialysis site, modality, product, and region. By type, it is bifurcated into hemodialysis and peritoneal dialysis. The hemodialysis segment is further divided into short-term catheter, chronic catheter, graft, and fistula. By dialysis site, the market is classified into hospitals, clinics & dialysis centers, and home dialysis. The home dialysis segment is further classified into home hemodialysis and home peritoneal dialysis. By modality, it is categorized into conventional and daily (day time, night time). By product, it is segmented into devices and consumables. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Type Segment Review
Hemodialysis segment is the major contributor toward the market growth, owing to maturity of the hemodialysis and peritoneal dialysis market and is a preferred form of approach among healthcare professionals and patients suffering from end-stage renal disease (ESRD). There are two types of hemodialysis, namely, conventional and daily (short daily and nocturnal hemodialysis). However, owing to efficient removal of toxic substances and rise in demand for homecare among dialysis patients, peritoneal dialysis is expected to be the fastest growing segment during the forecast period.
By Type
Hemodialysis segment held a dominant position in 2019 and would continue to maintain the lead over the forecast period.
Dialysis Site Segment Review
Most patients prefer to receive dialysis treatments through services provided by clinics & dialysis centers, making them the largest contributor to the global hemodialysis and peritoneal dialysis market. Nonetheless, rise in awareness and surge in demand for home healthcare among dialysis patients is expected to make home dialysis fastest growing segment during the forecast period.
By Dialysis Site
Clinics and Dialysis Centers segment held a dominant position in 2019 and would continue to maintain the lead over the forecast period.
Modality Segment Review
On the basis of modality, conventional hemodialysis is more frequently used treatment, however, owing to efficient removal of toxic substances and demand for homecare among dialysis patients, daily dialysis is expected to be the fastest growing segment during the forecast period.
By Modality
Conventional dialysis segment was holding a dominant position in 2019 and would continue to maintain the lead over the forecast period.
Product Segment Review
On the basis of product, consumables are expected to be the fastest growing segment as these products are used frequently, and are constantly needed to be replaced with new ones. For instance, companies are developing catheters for advanced materials that are resistant to chemicals, such as peroxide, iodine, or alcohol. These progressions help increase longevity of catheters and reduce risk of any malfunction. Moreover, there is a growth in demand for antimicrobial coated catheters, which reduces the rate of bloodstream infections. Similarly, innovative technologies used in manufacturing of dialyzers such as increased surface contact and cut‐off membrane dialyzers for better diffusion positively impact on growth of the consumable segment.
By Product
Consumables segment is projected as one of the most lucrative segment.
Region Segment Review
Asia-Pacific constituted highest hemodialysis and peritoneal dialysis market share in 2019, followed by North America and LAMEA. Asia-Pacific accounted for about 42.3% share in 2019, owing to increase in awareness about advanced dialysis devices among healthcare professionals & patients, developing healthcare infrastructure, and higher prevalence of ESRD. Overall, it is projected that need for dialysis in developing countries of Asia-Pacific would rise sharply in the coming years, reaching higher levels than American and European countries. This is majorly attributed to larger number of undiagnosed patients with kidney related disorders and rise in market penetration by various pharmaceutical companies to reach the untapped regions for geographical expansion.
By Dialysis Site
Clinics and Dialysis Centers segment held a dominant position in 2019 and would continue to maintain the lead over the forecast period.
Key Benefits For Stakeholders
- This report provides a detailed quantitative analysis of the current hemodialysis and peritoneal dialysis market trends and forecast estimations from 2020 to 2027, which assists to identify the prevailing market opportunities.
- An in-depth hemodialysis and peritoneal dialysis market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
- A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
- The projections in this report are made by analyzing the current trends and future market potential from 2020 to 2027, in terms of value.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
- Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the hemodialysis and peritoneal dialysis market.
Hemodialysis and Peritoneal Dialysis Market Report Highlights
Aspects | Details |
By Type |
|
By Dialysis Site |
|
By Modality Type |
|
By Product |
|
By Region |
|
Key Market Players | FRESENIUS SE AND CO. KGAA, NIKKISO CO. LTD., B. BRAUN MELSUNGEN AG, NIPRO CORPORATION, ASAHI KASEI CORPORATION, BAXTER INTERNATIONAL INC., ANGIODYNAMICS INC., COOK GROUP, MEDTRONIC PLC., BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.) |
Analyst Review
Hemodialysis and peritoneal dialysis is the most popular and preferred form of treatment for chronic renal diseases and kidney failures as compared to kidney transplantation. On the contrary, factors, such as non-eligibility of patients suffering from heart or liver disease for kidney transplantation, rise in incidences of kidney failures, growth in number of ESRD patients, increase in occurrences of diabetes, surge in funding for development of new products with advanced technology, and lack of matching donors for kidney transplantation are expected to propel growth of the hemodialysis and peritoneal dialysis market during the forecast period. However, lack of awareness about kidney diseases, complications associated with hemodialysis and peritoneal dialysis treatments, and reduction in reimbursements for dialysis across developing nations are expected to obstruct the market growth. The peritoneal dialysis segment is predicted to grow at the highest rate and offer beneficial opportunities for market players. Peritoneal dialysis is preferred over hemodialysis, owing to advantages it offers, such as low number of clinical visits, negligible usage of needles, and easy-to-use machinery, which boosts the segment growth.
The use of hemodialysis and peritoneal dialysis is highest in Asia-Pacific, owing to increase in adoption of these products, high prevalence rate of diabetes and hypertension, and rise in awareness regarding various kidney diseases among population. Although use of hemodialysis and peritoneal dialysis in Europe and LAMEA is low, the adoption rate is expected to increase, owing to rise in disposable income, increase in the incidence rate of kidney failures, and presence of large geriatric population.
The key trends in the Hemodialysis and Peritoneal Dialysis Market are rise in incidences of kidney diseases globally and increase in occurrences of lifestyle and chronic diseases.
The top companies that hold the market share in Hemodialysis and Peritoneal Dialysis Market are Fresenius, Nipro Corporation, B. Braun, Nikkiso, and Baxter International Inc.
No, there is no value chain analysis provided in the Hemodialysis and Peritoneal Dialysis Market report
The total market value of Hemodialysis and Peritoneal Dialysis Market is $22,164.86 million
The forecast period in the report is from 2020 to 2027
The market value of Hemodialysis and Peritoneal Dialysis Market in 2019 was $15,681.8 Million
The base year for the report is 2019
Yes, Hemodialysis and Peritoneal Dialysis companies are profiled in the report
Loading Table Of Content...